The Senate Finance Committee is widening a probe into tax-exempt organizations — including patient advocacy groups and medical associations — that have financial ties with opioid makers in a bid to shed light on the extent to which these relationships affected the ongoing opioid crisis afflicting the U.S.
Last Friday, letters were sent by Sen. Chuck Grassley (R-Iowa), who heads the committee, and Sen. Ron Wyden (D-Ore.), the minority leader, to 10 organizations, including the Federation of State Medical Boards, which supports physician licensing and regulation; The Joint Commission, which accredits health care organizations; and such groups as the American Chronic Pain Association and the American Society of Pain Educators.
About the Author Reprints
And can we check to see what financial ties senators have with opioid makers?